Boehringer Ingelheim GmbH / Hisamitsu
Completed divestiture via carve-out of Nippon Boehringer Ingelheim’s prescription generics business in Japan (Total sales €100m in 2003) including a guarantee payment by Boehringer Ingelheim for a 2 Year post-closing employment continuation.
Completed divestiture via carve-out of Nippon Boehringer Ingelheim’s prescription generics business in Japan (Total sales €100m in 2003) including a guarantee payment by Boehringer Ingelheim for a 2 Year post-closing employment continuation.